Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUBP2 (Cytosolic Fe-S cluster assembly factor NUBP2) is an ATP- and metal-binding protein required for the biogenesis and maturation of extramitochondrial (mainly cytosolic and nuclear) iron-sulfur (Fe-S) cluster-containing proteins in mammalian cells[1][3][7]. It forms a heterotetrameric scaffold complex with its paralog NUBP1, mediating de novo assembly of Fe-S clusters for transfer to target apoproteins[7]. NUBP2 belongs to the NUBP/MRP subfamily of P-loop NTPases and has homology to cell division proteins in prokaryotes[3][4]. Mutations or disruptions in NUBP2 impair Fe-S protein maturation, affecting numerous cellular processes that depend on functional Fe-S clusters, and are associated with certain neurodegenerative diseases[7]. There are no established direct drug interactions or biomarker applications. NUBP2 is not considered a conventional therapeutic target such as a receptor, enzyme, or transporter, but is critical for basic cellular iron-sulfur metabolism and protein assembly[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic Fe-S cluster assembly factor NUBP2 (NUBP2).